Related by context. All words. (Click for frequent words.) 77 metastatic NSCLC 77 unresectable locally advanced 76 unresectable 75 metastatic pancreatic cancer 74 metastatic HER2 negative 72 gemcitabine chemotherapy 72 recurrent metastatic 72 non squamous NSCLC 71 advanced SCCHN 71 stage IIIb IV 71 recurrent NSCLC 71 metastatic colorectal 70 metastatic HER2 positive 70 evaluating ispinesib 70 metastatic gastric 70 stage IIIB 69 metastatic carcinoma 69 5 fluorouracil leucovorin 69 HER2 positive metastatic breast 69 metastatic bladder 69 fallopian tube carcinoma 69 metastatic RCC 69 metastatic GIST 68 anthracycline taxane 68 advanced metastatic renal 68 metastatic pancreatic 67 Hepatocellular Carcinoma HCC 67 lenalidomide Revlimid R 67 ZACTIMA 67 metastatic hormone refractory 67 evaluating picoplatin 67 TNFerade ™ 67 mRCC 67 metastatic malignant 67 dasatinib Sprycel ® 67 unresectable Stage III 66 AGILECT R 66 resectable 66 unresectable tumors 66 metastatic renal cell carcinoma 66 recurrent prostate cancer 66 chemotherapy cisplatin 66 evaluating T DM1 66 metastatic castrate resistant 66 Vicinium TM 66 tumors GIST 66 metastatic CRC 66 docetaxel Taxotere R 66 pegylated interferon alfa 2a 66 Amrubicin 66 Peginterferon alfa 2b 66 refractory metastatic colorectal cancer 66 TNFerade TM 66 sorafenib tablets 66 evaluating tivozanib 65 refractory chronic lymphocytic 65 concurrent chemoradiation 65 docetaxel Taxotere ® 65 eribulin mesylate 65 plus gemcitabine 65 refractory cutaneous T 65 refractory NSCLC 65 stage IIIA 65 metastatic HER 65 metastatic renal cell 65 LHRH receptor positive 65 erlotinib Tarceva ® 65 VEGFR2 inhibitor 65 CYT# potent vascular disrupting 65 metastatic colorectal carcinoma 65 chemoradiotherapy 65 pegylated liposomal doxorubicin 65 KRAS mutations occur 65 FOLFOX6 65 BRIM2 65 AVASTIN 65 Kit CD# positive 65 non squamous 65 recurrent glioblastoma multiforme 65 Aflibercept 64 Gliadel Wafer 64 estramustine 64 stage IIIB IV 64 irinotecan doxorubicin oxaliplatin paclitaxel 64 docetaxel chemotherapy 64 non splenectomized 64 R sorafenib tablets 64 dacarbazine 64 metastatic CRPC 64 radiation chemoradiation 64 BCG refractory 64 Fludara ® 64 HER2 negative 64 Navelbine ® 64 nonmetastatic 64 receptor tyrosine kinase inhibitor 64 relapsed MM 64 cisplatin gemcitabine 64 Irinotecan 64 nilotinib Tasigna ® 64 essential thrombocythemia ET 64 TTF Therapy 64 Patients Treated With 64 epirubicin 64 Fludarabine 64 metastatic androgen independent 64 carcinoma HCC 64 acyclovir Lauriad R 64 HBeAg negative 64 opioid induced constipation OIC 64 luteinizing hormone releasing 64 gefitinib Iressa 64 resistant hormone refractory 64 pancreatic adenocarcinoma 64 cutaneous T 63 FUSILEV enhances 63 assessing T DM1 63 papillary renal cell carcinoma 63 cetuximab Erbitux R 63 sorafenib Nexavar 63 metastatic castration resistant 63 Tarceva TM 63 advanced hepatocellular carcinoma 63 relapsed leukemia 63 prostate cancer HRPC 63 leukemia AML 63 medically inoperable 63 hormone refractory metastatic prostate 63 taxane chemotherapy 63 malignant pleural mesothelioma 63 intravesical infusion therapy 63 epithelial ovarian 63 CTA# Injection 63 interferon gamma 1b 63 carboplatin paclitaxel 63 5 FU leucovorin 63 myelodysplastic myeloproliferative diseases 63 alkylating agent 63 advanced HER2 positive 63 hormone receptor positive 63 Previously Untreated 63 metastatic breast cancer 63 ® lenalidomide 63 bone marrow reticulin deposition 63 Gemzar ® 63 docetaxel Taxotere 63 sorafenib Nexavar ® 63 Renal Cell Carcinoma RCC 63 HGS ETR1 63 histologically confirmed 63 neoadjuvant treatment 63 YONDELIS 63 lintuzumab SGN 63 minimally symptomatic 63 acting corticosteroid 63 vinca alkaloid 63 antibody MAb 63 Folfox 63 Taxotere docetaxel 63 relapsed refractory multiple myeloma 63 cell lymphoma CTCL 63 cell carcinoma RCC 63 systemic anaplastic large 63 paclitaxel Taxol R 63 hormone LHRH agonist 63 metastatic adenocarcinoma 63 oral chemotherapeutic agent 63 cisplatin vinorelbine 63 EGFR expressing mCRC 63 Proxinium TM 63 non metastatic osteosarcoma 63 EGFR TKI 63 FOLFIRI 63 Advanced Renal Cell 63 monoclonal antibody conjugated 63 Hormone Refractory Prostate Cancer 63 PEGylated Fab fragment 63 Pegasys ® 63 platinum refractory 63 adriamycin 63 hormone refractory prostate cancer 62 modified glutathione analog 62 Ixempra 62 cyclophosphamide methotrexate 62 transplantation HCT 62 BCG refractory carcinoma 62 temsirolimus 62 VELCADE melphalan 62 biliary tract cancer 62 neoadjuvant chemotherapy 62 comparator arm 62 Annamycin 62 situ CIS 62 oral ridaforolimus 62 metastatic breast 62 EGFR expressing metastatic colorectal 62 gastrointestinal stromal tumor GIST 62 epirubicin cyclophosphamide 62 Troxatyl 62 sunitinib malate 62 VALSTAR TM 62 metastatic lung cancer 62 cutaneous T cell 62 SPRYCEL ® 62 CML CP 62 ACTEMRA TM 62 paclitaxel cisplatin 62 Platinol ® cisplatin 62 paclitaxel Taxol ® 62 achieved ACR# 62 neoadjuvant 62 lung pancreatic 62 trastuzumab Herceptin R 62 oropharyngeal candidiasis OPC 62 HGS ETR1 mapatumumab 62 dasatinib Sprycel 62 Xelox 62 dacarbazine DTIC 62 plus prednisone 62 alvespimycin 62 Nexavar ® 62 squamous non 62 KRAS wild 62 sunitinib Sutent 62 alpha interferons 62 FIRMAGON 62 Metastatic Colorectal Cancer 62 interferon alfa 2a 62 paclitaxel chemotherapy 62 EFAPROXYN 62 trabectedin 62 non resectable 62 advanced metastatic prostate 62 herpetic keratitis 62 4mg/kg 62 PD LID 62 Unresectable 62 taxane refractory 62 ribavirin RBV 62 castrate resistant 62 chemoradiation therapy 62 IgG1 monoclonal antibody 62 metastatic renal 62 chlorambucil 62 Torisel 62 IV NSCLC 62 PEGINTRON TM 61 vandetanib 61 generation purine nucleoside 61 8mg/kg 61 immunotherapeutic agent 61 Refractory Hodgkin Lymphoma 61 unresectable stage 61 familial amyloidotic polyneuropathy FAP 61 ThermoDox R 61 Certolizumab pegol 61 ErbB2 positive 61 metastatic ocular 61 colorectal lung 61 metastatic 61 de novo kidney transplant 61 unresectable liver cancer 61 alpha folate receptor 61 humanized interleukin 6 61 nonsquamous histology 61 orally administered inhibitor 61 paclitaxel carboplatin 61 Complicated Skin 61 Camptosar ® irinotecan 61 fallopian tube cancers 61 Platinol 61 metastatic neuroendocrine tumors 61 imatinib Gleevec ® 61 irinotecan chemotherapy 61 neoadjuvant therapy 61 INSPIRE Trial Phase III 61 gemcitabine carboplatin 61 soft tissue sarcomas 61 Clolar ® 61 hepatocellular cancer 61 phase IIb clinical 61 diagnosed glioblastoma multiforme 61 Flu Cy 61 CIMZIA ™ 61 LymphoStat B belimumab 61 advanced epithelial ovarian 61 gastrointestinal stromal tumors 61 ELACYT 61 Glufosfamide 61 huC# DM4 61 thalidomide Thalomid 61 Xeloda capecitabine 61 metastatic medullary thyroid 61 IMA# 61 histone deacetylase HDAC inhibitor 61 HRPC 61 advanced NSCLC 61 FOLFOX4 61 Nexavar sorafenib 61 Camptosar ® 61 metastatic HRPC 61 anaplastic astrocytoma AA 61 gemcitabine Gemzar 61 novel VDA molecule 61 Velcade bortezomib 61 deep venous thromboses 61 castrate resistant prostate cancer 61 EGFR expressing 61 pain palliation 61 distant metastasis 61 Erlotinib 61 3 registrational trial 61 Relapsed Multiple Myeloma 61 Pemetrexed 61 reduce serum phosphate 61 Cutaneous T 61 metastatic liver 61 plus dexamethasone 61 Gemcitabine 61 underwent surgical resection 61 vinorelbine tartrate 61 Elotuzumab 61 Voreloxin 61 Besivance 61 Taxotere ® 61 PROVENGE ® 61 Genasense ® 61 CTAP# Capsules 61 beclomethasone dipropionate 61 xanthine oxidase inhibitor 61 Group RTOG 61 TAXOTERE R 61 refractory multiple myeloma 61 refractory AML 61 adalimumab Humira 61 cisplatin chemotherapy 61 Xeloda ® 61 gemcitabine cisplatin 61 AVOREN 61 alfa 2a 61 candidate TNFerade biologic 61 TAXOTERE ® 61 capecitabine Xeloda 61 peginterferon alfa 2a Pegasys 61 Vandetanib 61 Naive Patients 61 pemetrexed 61 Fludara 61 Castration Resistant Prostate Cancer 61 Phase #/#a trial 61 untreated metastatic pancreatic 60 mTOR inhibitor 60 PANVAC VF 60 cetuximab Erbitux ® 60 severe oral mucositis 60 Copegus ribavirin 60 candidate XP# 60 interferon ribavirin 60 R lenalidomide 60 RoACTEMRA 60 leukemia CLL 60 MKC# MT 60 radiochemotherapy 60 advanced pancreatic neuroendocrine 60 MAGE A3 ASCI 60 dependent kinase inhibitor 60 colorectal cancer liver metastases 60 advanced medullary thyroid 60 Combination REOLYSIN R 60 Phase #b/#a clinical 60 delivers fluocinolone acetonide FA 60 nilotinib Tasigna 60 LEUKINE 60 carboplatin chemotherapy 60 arsenic trioxide injection 60 hypereosinophilic syndrome 60 Syndrome LEMS 60 cetuximab Erbitux 60 Neoadjuvant 60 EGFR mutation positive 60 oncolytic virus therapies 60 FOLFOX 60 Hycamtin ® 60 superficial bladder cancer 60 aplastic anemia AA 60 taxane chemotherapy administered 60 carmustine 60 IIb clinical trial 60 plus prednisone prednisolone 60 subependymal giant cell 60 mGluR5 negative 60 CHOP chemotherapy 60 metastatic colorectal cancer 60 including eniluracil ADH 60 RANK Ligand inhibitor 60 HER2 positive 60 pertuzumab 60 differentiated thyroid 60 metastatic SCCHN 60 nonsmall cell lung cancer 60 Degarelix 60 SHPT 60 squamous histology 60 Tarceva erlotinib 60 relapsed acute lymphoblastic 60 CDK cyclin dependent 60 Alemtuzumab 60 Metastatic Breast Cancer 60 Metastatic Pancreatic Cancer 60 TELINTRA R 60 metastatic prostate cancer 60 predominantly classic subfoveal 60 GW# [003] 60 irinotecan containing 60 TORISEL 60 EOquin TM phase 60 forodesine 60 FOLFOX6 chemotherapy regimen 60 untreated metastatic colorectal 60 custirsen 60 Adjuvant Treatment 60 gemcitabine Gemzar ® 60 Motesanib 60 primary peritoneal 60 kidney urologic 60 underwent resection 60 gastrointestinal stromal tumor 60 vinca alkaloids 60 Aplidin 60 diagnosed GBM 60 registrational trial 60 systemic ALCL 60 brand ciclesonide HFA 60 Bezielle 60 pharmacologically active isomer 60 nasopharyngeal carcinoma 60 eribulin 60 mitoxantrone plus 60 infusional 5-FU/LV 60 IRESSA 60 chemotherapy FOLFOX 60 nucleoside analog 60 Surgical resection 60 relapsed CLL 60 unresectable hepatocellular carcinoma HCC 60 Metastatic Prostate Cancer 60 Azacitidine 60 Relapsed Refractory 60 Soft Tissue Sarcoma 60 lymphoma CTCL 60 relapsed multiple myeloma 60 hepatic metastases 60 multi kinase inhibitor 60 Trabectedin 60 COMBIVIR 60 OMP #R# 60 IL# PE#QQR 60 anti EGFR antibody 60 ovarian breast 60 MYLOTARG 60 epithelial tumors 60 Carcinoid tumors 60 liposomal doxorubicin 60 Trastuzumab 60 MabCampath 60 castration resistant prostate cancer 60 Lenalidomide 60 pegfilgrastim 60 relapsing remitting MS RRMS 60 Votrient 60 nonsquamous 60 Sorafenib 60 investigational immunotherapy 60 Taxol ® 60 curative resection 60 immunomodulatory therapy 60 bladder ovarian 60 ORENCIA ® 60 renal cell carcinoma 60 myelodysplastic syndrome MDS 60 prostate cancer mCRPC 60 standard chemotherapy regimen 60 Capecitabine 60 Bayer HealthCare Onyx Pharmaceuticals 60 untreated metastatic melanoma 60 TACE 60 fluorouracil 60 HGS ETR2 60 cyclophosphamide chemotherapy 60 BARACLUDE ® 60 ovarian lung 60 anthracyclines taxanes 59 Gel repository corticotropin injection 59 GVAX ® 59 TO AVOID PREGNANCY WHILE 59 intravesical instillation 59 Stage IIIA 59 TNFerade 59 fluoropyrimidine 59 doublet chemotherapy 59 bevacizumab Avastin R 59 Relapsed Refractory Multiple Myeloma 59 Temsirolimus 59 rheumatoid arthritis psoriatic arthritis 59 potent triglyceride lowering 59 Vitrasert R 59 interferon alfa 59 catheter occlusion 59 recurrent metastatic ovarian cancer 59 non metastatic resectable 59 GI GVHD common 59 idarubicin 59 docetaxel prednisone 59 KNS # 59 ritonavir boosted 59 unresectable recurrent 59 remission induction 59 Gefitinib 59 lymphoid malignancies 59 Ribavirin causes 59 SinuNase TM 59 Squamous 59 anastrazole 59 Panzem NCD 59 injected subcutaneously 59 vinorelbine 59 multiple myeloma MM 59 RhuDex ® 59 randomized Phase III 59 diagnosed Ph + 59 IMiDs ® compound 59 PNP inhibitor 59 preoperative chemotherapy 59 anthracycline containing 59 SCCHN 59 BRCA deficient 59 Quinamed 59 complement inhibitor eculizumab 59 cisplatin resistant 59 ONCASPAR 59 small lymphocytic lymphoma 59 Daclizumab 59 Selective Internal 59 targeted radiotherapeutic 59 Taxotere R 59 completely resected 59 achieved CCyR 59 Ceflatonin 59 CINTREDEKIN BESUDOTOX 59 paclitaxel Taxol 59 5-FU/LV 59 BCR ABL inhibitor 59 adecatumumab 59 Diffuse Large B 59 EGFr expressing metastatic colorectal 59 cytologically confirmed 59 Cetuximab Erbitux 59 Leucovorin 59 Anthracycline 59 Zevalin R Ibritumomab 59 liposomal formulation 59 ZOLINZA 59 phase IIb study 59 skeletal metastases 59 melphalan prednisone 59 tiuxetan 59 brain metastases originating 59 PRN FDA Approves 59 Docetaxel 59 treatment naïve genotype 59 dopamine partial agonist 59 Chemoradiation 59 telomerase therapeutic 59 placebo dexamethasone 59 non splenectomised 59 locoregional recurrence 59 goserelin 59 oral picoplatin 59 Peginterferon 59 elevated transaminases 59 Accelerated Partial Breast Irradiation 59 MKC# MKC# PP 59 FOLFIRI alone 59 infliximab monotherapy 59 Ozarelix 59 localized renal 59 mCRC 59 metastatic malignant melanoma 59 candidates Azedra TM 59 chemotherapeutic regimens 59 cabazitaxel 59 CAELYX 59 Pegintron 59 Novantrone 59 haematologic 59 keloid scarring 59 albiglutide 59 Lambert Eaton Myasthenic 59 atypical Hemolytic Uremic Syndrome 59 oral nucleoside analogue 59 COPEGUS 59 ALVESCO ® 59 bevacizumab Avastin ® 59 oral allopurinol 59 peginterferon alfa 59 Thiarabine 59 BRIM3 59 Metastatic 59 intravesical therapy 59 Pivotal Phase 59 tolevamer 59 PSMA ADC 59 APTIVUS 59 BR.# 59 visilizumab 59 Advanced Prostate Cancer 59 FOLFIRI chemotherapy 59 vapreotide acetate 59 Onalta ™ 59 Peg IFN 59 ovarian esophageal 59 PREZISTA r 59 Cytoxan 59 trastuzumab DM1 T DM1 59 bevacizumab Avastin 59 clodronate 59 allogeneic stem cell 59 XL# anticancer compounds 59 ethambutol 59 gemcitabine 59 Paraplatin ® carboplatin 59 NMIBC 59 Bevacizumab 59 Oxaliplatin 59 Navelbine 59 gastrointestinal stromal tumors GIST 59 advanced carcinoid 59 Panzem R NCD 59 Cloretazine ® 59 Allovectin 7 59 tamoxifen Nolvadex ® 59 pancreatic NET 59 Xanafide 59 Inhalation Aerosol 59 personalized cellular immunotherapy 59 docetaxel 58 evaluating Nexavar 58 ovarian endometrial 58 sunitinib 58 cintredekin besudotox 58 mcg albinterferon alfa 2b 58 glioblastoma multiforme GBM 58 primary hypercholesterolemia 58 refractory acute myeloid 58 Brentuximab Vedotin SGN 58 Temodar ® 58 FASLODEX 58 nicardipine 58 mitoxantrone chemotherapy 58 dacarbazine chemotherapy 58 sorafenib Nexavar R 58 sorafenib 58 colorectal liver metastases 58 interferon alfa 2b 58 metaglidasen 58 Stage IIIb 58 EGFR tyrosine kinase inhibitor 58 FOLFOX chemotherapy 58 operable breast cancer 58 severe renal impairment 58 HGS# 58 alefacept 58 aflibercept VEGF Trap 58 q#h 58 virus HCV protease inhibitor 58 Thal Dex 58 epirubicin cisplatin 58 somatostatin analog 58 Jevtana 58 autoantibody positive 58 Metastatic Renal Cell Carcinoma 58 radiotherapeutic 58 R roscovitine CDK cyclin 58 AEG# 58 chronic ITP patients 58 adjuvant radiotherapy 58 CIMZIA TM 58 adjuvant radiation 58 investigational oral inhibitor 58 pazopanib 58 refractory indolent non 58 B CLL 58 alemtuzumab Campath 58 cytarabine daunorubicin 58 agonistic human 58 Uricase PEG 58 Myelodysplastic Syndrome 58 evaluating REVLIMID 58 Radiation Therapy SIRT 58 Intravitreal injections 58 alkylating agents 58 mCRC patients 58 treat benign prostatic 58 metastatic squamous cell carcinoma 58 PrevOnco 58 2 methoxyestradiol 58 squamous cell cancer 58 HBeAg positive patients 58 daunorubicin 58 demonstrated antitumor activity 58 chemotherapeutic agent 58 oral antidiabetic medication 58 topically applied SEPA 58 Neuvenge 58 Paraplatin ® 58 peripheral arterial occlusive disease 58 INCB# [003] 58 TBC# 58 exocrine pancreatic insufficiency EPI 58 Ophena TM 58 bleeding pallor 58 Is Well Tolerated 58 induced macular edema 58 intestinal metaplasia 58 tumor xenograft models 58 taxane resistant 58 EGFR TK 58 gefitinib 58 medullary thyroid cancer 58 peritoneal carcinomatosis 58 Albuferon TM 58 SCIg 58 pediatric Crohn disease 58 TYZEKA 58 following fluoropyrimidine oxaliplatin 58 melphalan 58 lenalidomide dexamethasone 58 prostate cancer CRPC 58 oral clodronate 58 commercialize deforolimus 58 hypercalcemia 58 Vidaza ® 58 follicular lymphoma FL 58 BAY #-# 58 naïve HCV 58 Halaven 58 sarcoma melanoma 58 angiogenesis inhibitor 58 biologic DMARD 58 axitinib 58 CIMZIA TM certolizumab pegol 58 iobenguane 58 Oral Fingolimod 58 neuroendocrine cancers 58 anaplastic astrocytoma 58 hepatitis C HCV 58 dose melphalan 58 CLL SLL 58 acetonide FA 58 Amgen Neulasta ® 58 leukotriene receptor antagonist 58 hormone LHRH antagonist 58 PI3K/Akt pathway inhibitor 58 Newly Diagnosed Multiple Myeloma 58 Pertuzumab 58 Gemzar gemcitabine 58 carcinoid tumors 58 flutamide 58 cediranib 58 L MTP PE 58 ribavirin therapy 58 Canvaxin TM 58 serologically active systemic lupus 58 PDX pralatrexate 58 Philadelphia Chromosome Positive 58 Atypical Hemolytic Uremic Syndrome 58 radiofrequency ablation RFA 58 stage IIIb 58 Solazed 58 aldehyde dehydrogenase ALDH2 deficiency 58 tenofovir emtricitabine 58 locoregional 58 T1c 58 KRAS mutant tumors 58 nucleoside analogue 58 AA amyloidosis 58 mildly symptomatic 58 Pirfenidone 58 Sodium oxybate 58 plus COPEGUS 58 toenail onychomycosis 58 novel emulsion formulation 58 hereditary deficiency 58 non squamous histology 58 TELCYTA 58 Eli Lilly Gemzar 58 PAOD 58 biologic therapy 58 liver metastases 58 recurrent glioblastoma 58 receiving highly emetogenic 58 Bosutinib 58 HER2 expressing 58 decompensated liver disease 58 glycoprotein IIb IIIa inhibitor 58 panitumumab Vectibix 58 pediatric acute lymphoblastic 58 chronic myeloid 58 EDEMA3 58 mycophenolic acid 58 metastatic relapsed 58 eosinophilic asthma 58 occlusion PAO 58 calcineurin inhibitor 58 common hematologic malignancy 58 Alkeran 58 oxypurinol 58 Ceplene/IL-2 58 R sipuleucel T 58 diagnosed multiple myeloma 58 standard chemotherapy regimens 58 cytoreduction 58 investigational humanized monoclonal antibody 58 TKI therapy 58 Bevacizumab Avastin 58 castration resistant 58 antithymocyte globulin 58 Methylnaltrexone 58 Idiopathic pulmonary fibrosis 58 Mitomycin C 58 basiliximab 58 heavily pretreated 58 5 fluorouracil 58 mapatumumab 58 Chronic Hepatitis C 58 doxorubicin cyclophosphamide 58 dexamethasone Decadron 58 regorafenib 58 AAG geldanamycin analog 58 Myelodysplastic Syndrome MDS 58 ER CHOP 58 idiopathic pulmonary fibrosis IPF 58 Lymphocytic 58 metformin HCl 58 endocrine therapies 58 non alcoholic steatohepatitis 58 Omacetaxine 58 oral vancomycin 58 DOXIL 58 abacavir lamivudine 58 Ph + ALL 58 investigational mTOR inhibitor 58 radiation sensitizer 58 Dementia Related Psychosis 58 bortezomib Velcade R 58 cancer mCRC 58 #mg/m# [002] 58 bosutinib 58 Neovascular AMD 58 brivanib 58 candidemia 58 evaluating satraplatin 58 5 Fluorouracil 58 Prednisone Against Refractory 58 biliary strictures produced 58 EGFR HER2 58 Fibrillex TM 58 treat chronic sinusitis 58 Stage IIIb IV 58 candidate ridaforolimus 58 Genasense oblimersen sodium Injection 58 Adjuvant Chemotherapy 58 #mg/m# [001] 58 clinically localized prostate 58 grade cervical intraepithelial 58 compound INCB# 58 elacytarabine 58 asymptomatic metastatic 58 monotherapy 58 included exfoliative dermatitis 58 neutropenia dehydration dyspnea 58 Femara letrozole 58 trastuzumab DM1 58 ASCT 58 indolent NHL 58 Cimzia certolizumab pegol 58 HRPC ovarian cancer 58 Renal Cell Carcinoma 58 malignant pleural mesothelioma MPM 58 lexidronam injection 58 ribavirin Copegus ® 58 μg dose 57 compound KOS 57 Kamada AAT 57 mutated KRAS 57 Nexavar tablets 57 oblimersen 57 basal cell carcinoma BCC 57 taxane 57 relapsed refractory AML 57 retinal vein occlusion induced 57 intra arterial chemotherapy 57 fluorouracil leucovorin 57 distant metastases 57 mg/m2 IV 57 cirrhosis liver failure 57 unresectable HCC 57 PrevOnco ™ 57 Erbitux cetuximab 57 evaluating Actimmune 57 LE DT 57 Acute Myelogenous Leukemia AML 57 FluCAM 57 Chronic Myelogenous Leukemia CML 57 zoledronate 57 Epratuzumab 57 IAP inhibitor 57 EOquin TM 57 TRAIL R1 57 Sanofi Aventis Taxotere 57 recurrent malignant glioma 57 TELINTRA 57 thetreatment 57 Acute Exacerbations 57 Tanespimycin 57 cetuximab 57 weekly subcutaneous injections 57 XELOX 57 Doxil ® 57 GnRH agonist 57 corticosteroid dexamethasone 57 ARIMIDEX 57 pancreatic carcinoma 57 Orally administered 57 Multiple Myeloma MM 57 Platinol ® 57 pheochromocytomas 57 chemoradiation 57 MET inhibitor 57 class anticancer quinolone 57 gastrointestinal mucositis 57 Iluvien ® 57 administered subcutaneously 57 Linaclotide 57 Alocrest 57 LBH# 57 Dasatinib 57 Hsp# Inhibitor 57 Chronic lymphocytic leukemia 57 methylnaltrexone bromide 57 peritoneal cancer 57 SUPPRELIN R LA 57 microtubule inhibitor 57 VANTAS R 57 posaconazole 57 resistant ovarian cancer 57 treat opioid induced 57 lapatinib Tykerb 57 Vidaza azacitidine 57 potentially hepatotoxic 57 steroid refractory ulcerative 57 surgically resectable 57 sargramostim 57 Idiopathic Pulmonary Fibrosis 57 allogeneic bone marrow 57 denileukin diftitox 57 XGEVA 57 mg m² 57 Hodgkin lymphoma HL 57 unstable angina UA 57 Etoposide 57 bronchogenic carcinoma 57 TOCOSOL Camptothecin 57 MEK Inhibitor 57 aromatase inhibitor AI 57 previously untreated follicular 57 Cleviprex TM clevidipine 57 MyVax R 57 relapsed SCLC 57 sodium glucose cotransporter 57 RELOVAIR ™ 57 chemoembolization 57 bortezomib Velcade 57 VNP#M 57 Cyclophosphamide 57 mutated KRAS gene 57 MGd 57 LymphoStat B TM 57 radiotherapy RT 57 refractory metastatic 57 pT2 57 myelofibrosis MF 57 Improves Outcomes 57 Glioblastoma Multiforme GBM 57 ara C 57 esophageal candidiasis 57 acute GvHD 57 ritonavir boosted lopinavir 57 Tiuxetan